Advasur, LLC Named RxInsider Top 500 Company

Pharmacy 500

Advasur, LLC has been named an RxInsider Top 500 Company in Healthcare Systems Development in 2024. The Pharmacy500 is awarded to 500 pharmacy supply chain businesses and associations that significantly impacted dispensing pharmacies in the U.S. over the past year. More information is available at: https://rxinsider.com/Pharmacy500.php  

Cavazzoni: No more ‘kicking the can’ down the road for DSCSA compliance

WASHINGTON – The US Food and Drug Administration (FDA) does not intend to further delay enforcement of requirements for manufacturers’ track and trace verification systems under the Drug Supply Chain Security Act (DSCSA) and expects those systems to be up and running this November, asserted Patrizia Cavazzoni, director of the agency’s Center for Drug Evaluation and Research […]

SuiteRx Partners with Advasur

SuiteRx has partnered with Advasur LLC to provide our valued clients, a seamless intelligent Track and Trace Reporting Solution to ensure your dispensary(s) are compliant with the Drug Supply Chain Security Act (DSCSA), current and upcoming mandates. KEY COMPONENTS INCLUDE: Uniformly Validate, Set-Up, and Maintained Suppliers Data Other industry service providers have limited capabilities and […]

SoftWriters Announces Partnership with Advasur

Relationship Will Aid Long-Term Care Pharmacies in Regulatory Compliance SoftWriters, Inc., the industry leader in long-term care (LTC) pharmacy software, is excited to partner with Advasur360, a comprehensive suite of Drug Supply Chain Security Act services. At SoftWriters, our mission is to save lives. We provide software solutions for the entire long-term care pharmacy ecosystem. […]

Operation Pangea XVI Seizes $7 Million in Counterfeit Drugs

LYON, France – The results of a major operation to crack down on illicit medicines across 89 countries have been announced today. The annual campaign targets illicit medicines that pose a significant threat to consumer safety, including counterfeit medicines and medicines diverted from legal and regulated supply chains. They also represent a major source of […]

Update – Enhanced Drug Distribution Security Requirements Under Section 582

FDA is issuing this guidance for immediate implementation in accordance with 21 CFR 10.115(g)(2). Submit one set of either electronic or written comments on this guidance at any time. Submit electronic comments to https://www.regulations.gov. Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. […]